New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura
Terry Gernsheimer TERRY GERNSHEIMER, University of Washington Medical Center, Seattle An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chroni
Terry Gernsheimer
TERRY GERNSHEIMER, University of Washington Medical Center, SeattleAn investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial that randomized patients to receive either the novel agent or a placebo. Sarah Maxwell spoke to study authorTerry Gernsheimerfrom the University of Washington during the American Society of Hematology meeting in Atlanta.
Tags
Related Episodes
Obesity, Car Travel, Climate Change: Linked?
Phil Edwards Phil Edwards, London School of Hyugiene and Tropical Medicine LSHTM Audio News Obesity Linked to Motor Transport And Climate Change Peter Goodwin questions Phil Edwards of the London Scho
Audio Journal of Oncology Volume 16 Number 11
Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology
Blind For Blindness: Preventing Childhood Blindness
Hessom Razavi, Puneet Sayal, Claire Gilbert Hessom Razavi, Puneet Sayal, Claire Gilbert, London School of Hygiene and Tropical Medicine Eye doctor Hessom Razavi volunteered to go about his usual studi